Related references
Note: Only part of the references are listed.Hemorrhagic complications of anticoagulant and thrombolytic treatment
Sam Schulman et al.
CHEST (2008)
Increased expression of VEGF and CD146 in patients with inflammatory bowel disease
G. Tsiolakidou et al.
DIGESTIVE AND LIVER DISEASE (2008)
NF-κB in inflammatory bowel disease
I. Atreya et al.
JOURNAL OF INTERNAL MEDICINE (2008)
Endothelial capillary tube formation and cell proliferation induced by tumor cells are affected by low molecular weight heparins and unfractionated heparin
Marina Marchetti et al.
THROMBOSIS RESEARCH (2008)
Unravelling the pathogenesis of inflammatory bowel disease
R. J. Xavier et al.
NATURE (2007)
CD14 is an essential mediator of LPS-induced airway disease
David M. Brass et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Functional modulation of crohn's disease myofibroblasts by anti-tumor necrosis factor antibodies
Antonio Di Sabatino et al.
GASTROENTEROLOGY (2007)
Gastroenterology 2 - Inflammatory bowel disease: clinical aspects and established and evolving therapies
Daniel C. Baumgart et al.
LANCET (2007)
Isolation and characterization of a heparin with low antithrombin activity from the body of Styela plicata (Chordata-Tunicata). Distinct effects on venous and arterial models of thrombosis
Joana C. Santos et al.
THROMBOSIS RESEARCH (2007)
In vivo antithrombotic properties of a heparin from the oocyte test cells of the sea squirt Styela plicata (Chordata-Tunicata)
L. Cardilo-Reis et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2006)
Critical appraisal of the current practice in murine TNBS-induced colitis
Anje A. te Velde et al.
INFLAMMATORY BOWEL DISEASES (2006)
Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions
Bernadette Begue et al.
GASTROENTEROLOGY (2006)
Role of angiogenesis in inflammatory bowel disease
Ioannis E. Koutroubakis et al.
INFLAMMATORY BOWEL DISEASES (2006)
Infliximab for induction and maintenance therapy for ulcerative colitis
P Rutgeerts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Tumor necrosis factor (TNF) α increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2
AL Theiss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Elevated circulating platelet-derived microparticles in patients with active inflammatory bowel disease
A Andoh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Biochemical and immunohistochemical analysis of glycosaminoglycans in inflamed and non-inflamed intestinal mucosa of patients with Crohn's disease
CLR Belmiro et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2005)
Inhibition of RICK/nuclear factor-κB and p38 signaling attenuates the inflammatory response in a murine model of Crohn Disease
E Hollenbach et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Immunity, inflammation, and allergy in the gut
TT MacDonald et al.
SCIENCE (2005)
Infliximab maintenance therapy for fistulizing Crohn's disease
BE Sands et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Critical involvement of stress-activated mitogen-activated protein kinases in the regulation of intracellular adhesion molecule-1 in serosal fibroblasts isolated from patients with Crohn's disease
DJ Beddy et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2004)
Smad7 in TGF-β-mediated negative regulation of gut inflammation
G Monteleone et al.
TRENDS IN IMMUNOLOGY (2004)
The impact of heparin compounds on cellular inflammatory responses: A construct for future investigation and pharmaceutical development
E Elsayed et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2003)
Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight
AA Khorana et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Inflammatory bowel disease
DK Podolsky
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins
LC Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Structure and anticoagulant properties of sulfated glycosaminoglycans from primitive Chordates
MSG Pavao
ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2002)
Altered response of intestinal mucosal fibroblasts to profibrogenic cytokines in inflammatory bowel disease
IC Lawrance et al.
INFLAMMATORY BOWEL DISEASES (2001)
Loss of transforming growth factor β signalling in the intestine contributes to tissue injury in inflammatory bowel disease
KB Hahm et al.
GUT (2001)
Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-κB activation in endothelial cells
I Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Inflammation location, but not type, determines the increase in TGF-β1 and IGF-1 expression and collagen deposition in IBD intestine
IC Lawrance et al.
INFLAMMATORY BOWEL DISEASES (2001)
Heparin and low-molecular-weight heparin - Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety
J Hirsh et al.
CHEST (2001)
Review article: potential therapeutic applications and mechanisms of action of heparin in inflammatory bowel disease
A Papa et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2000)
Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease
YS Ang et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2000)
Heparanase, a potential regulator of cell-matrix interactions
LA Dempsey et al.
TRENDS IN BIOCHEMICAL SCIENCES (2000)
Share Paper
